Jane Huang - 16 Jun 2021 Form 4 Insider Report for BeiGene, Ltd. (ONC)

Role: CMO, Hematology
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 16 Jun 2021
Net transactions value: -$152,733
Form type: 4
Filing time: 21 Jun 2021, 16:45:53 UTC
Previous filing: 10 Jun 2021
Next filing: 30 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	Ordinary Shares	Award	$0	+25,350	+9.1%	$0.000000	304,186	16 Jun 2021	Direct	F1
transaction	BGNE	American Depositary Shares	Sale	$152,733	-469	-100%	$325.66	0	18 Jun 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BGNE	Share Option (Right to Buy)	Award	$0	+157,196		$0.000000	157,196	16 Jun 2021	Ordinary Shares	157,196	$26.53	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
F2	Each American Depositary Share ("ADS") represents 13 Ordinary Shares.
F3	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
F4	The number of securities underlying the option and the exercise price therefor are represented in ordinary shares.
F5	These securities vest over a four-year period as follows: 25% on June 16, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.